|
Status |
Public on Mar 23, 2020 |
Title |
AmpliSeq Transcriptome profiling of human B cells from EBV-infected and FK506-treated humanized mice. |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
to investigate the effects of FK506 on the course of EBV infection in vivo
|
|
|
Overall design |
we reconstituted NOD-scid IL2Rγc−/− HLA-A2 transgenic mice with CD34+ hematopoietic progenitor cells (HPC) from HLA-A2+ human fetal livers. Upon assessment of human immune cell reconstitution in the peripheral blood at three to four-months after HPC injection, mice were infected with EBV (strain B95-8) or mock-infected with PBS. Three weeks post-infection (p.i.), animals were either treated with subcutaneous (s.c.) injections of FK506 (Tacrolimus) every second day or left untreated for a further two weeks.
|
|
|
Contributor(s) |
Caduff N, McHugh D, Prummer M, Hoffmann L, Raulf F, Rubic-Schneider T, Traggiai E, Kammüller M, Münz C |
Citation(s) |
32251475 |
|
Submission date |
Feb 13, 2019 |
Last update date |
Apr 27, 2020 |
Contact name |
Christian Münz |
E-mail(s) |
muenzc@immunology.uzh.ch
|
Organization name |
University Of Zurich
|
Department |
Institute of Experimental Immunology
|
Lab |
Viral Immunobiology
|
Street address |
Winterthurerstrasse 190
|
City |
Zurich |
ZIP/Postal code |
8057 |
Country |
Switzerland |
|
|
Platforms (1) |
|
Samples (26)
|
|
Relations |
BioProject |
PRJNA522254 |
SRA |
SRP185825 |